TRIB TRINITY BIOTECH PLC
Price Chart
Executive Summary
The SEC declared effective Trinity Biotech's F-3 shelf registration (File No. 333-295842) on May 22, 2026, enabling the company to sell securities on a delayed or continuous basis. This follows prior F-1 registrations for resale of up to 55.9M ADSs by Perceptive Credit Holdings, and a separate F-1 for up to 35.3M ADSs under a Standby Equity Purchase Agreement with YA II PN, Ltd. The shelf activation creates ongoing dilution overhang for a micro-cap company already under Nasdaq compliance review with $134.58M in debt.
Actionable Insight
The shelf effectiveness, combined with two active resale registrations from creditors, signals persistent dilution pressure. Monitor for any takedown announcements under the shelf or further conversions by Perceptive/YA II — each conversion at a discount to market will pressure TRIB shares. The cross-filing context (F-1 registrations + debt overhang) amplifies the bearish read-through.
Key Facts
- Effectiveness date: May 22, 2026 for F-3 shelf registration (File No. 333-295842)
- Prior F-1 (Jan 15, 2026) registers up to 55,890,900 ADSs (1,117,818,000 ordinary shares) for resale by Perceptive Credit Holdings, convertible from $60M note at 97% of VWAP with a $1.03 floor
- Prior F-1 (Feb 25, 2026) registers up to 35.3M ADSs for resale by YA II PN, Ltd. under Standby Equity Purchase Agreement, allowing up to $25M in sales at market discount over 3 years
- Company has $134.58M in debt and is under Nasdaq compliance review for low bid price and market value
- Market cap is approximately $12M, making dilution from these registrations highly material
Financial Impact
Combined potential dilution from up to 91.2M ADSs (55.9M + 35.3M) against a $12M market cap; existing $60M convertible note and $25M standby equity facility create severe dilution risk
Risk Factors
- Massive dilution from up to 91.2M ADSs registered for resale relative to $12M market cap
- Convertible note conversions at 97% of VWAP with $1.03 floor create persistent selling pressure
- Nasdaq compliance risk for low bid price and market value could lead to delisting
- Debt of $134.58M far exceeds market cap, raising solvency concerns
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001746 |
| Document: 9999999995-26-001746-index.html | 9999999995-26-001746 |
| Document: 9999999995-26-001746.txt | 9999999995-26-001746 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
6d ago
|
F-1/A
| $0.6800 $0.6700 | ▲ +1.47% | ▼ −1.13% | $0.6800 (−0.00%) |
|
May 26, 2026
15d ago
|
EFFECT
| $0.6500 $0.6800 | ▼ −4.62% | ▼ −4.60% | $0.6800 (−4.62%) |
|
Mar 23, 2026
11w ago
|
Press Release
| $0.6000 $0.6100 | ▲ +1.67% | ▲ +2.02% | $0.6800 (+13.33%) |
|
Mar 4, 2026
14w ago
|
EFFECT
| $0.7000 $0.7300 | ▲ +4.29% | ▲ +4.86% | $0.6800 (−2.86%) |
|
Feb 25, 2026
14w ago
|
F-1
| $0.7500 $0.7200 | ▲ +4.00% | ▲ +3.45% | $0.6800 (+9.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access